James Walsh

James Walsh is a seasoned professional in business development and publishing, currently serving as the Director of Business Development at Hyperion Biotechnology, Inc. since January 2023, focusing on the implementation of fatigue testing technology within corporate occupational healthcare. Previously, Walsh held the role of Acquisitions Editor and Internship Director at MERCURY LEARNING AND INFORMATION, where innovative publishing programs were established. Experience includes a significant tenure as Sales Consultant at Hyperion, promoting fatigue testing technology in athletics, as well as leadership roles at Baseball Prospectus and Maple Street Press, where strategic acquisitions and business development were pivotal. Educational background includes studies at the University of Notre Dame.